Hepatitis B Seroprevalence and Consequences in Khyber Pakhtunkhwa Peshawar, Pakistan
Last updated: 03 Jan 2025
10.21608/eajbsc.2023.291983
HBV, ELISA, ICT, virus, Antiviral
Saad
Alghamdi
Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
ssalghamdi@uqu.edu.sa
Saudi Arabia
Anas
Dablool
S.
Department of Public Health, Health Sciences College at Al-Leith, Umm Al-Qura University, Makkah, Saudi Arabia.
Saui Arabia
Nabeela
Al-Abdullah
King Abdulaziz University, Faculty of Nursing, Public Health Department, infection control unit, King Abdulaziz university hospital Jeddah, Saudi Arabia
Saudi Arabia
15
1
38909
2023-06-01
2023-01-21
2023-03-26
295
304
2090-0767
2090-083X
https://eajbsc.journals.ekb.eg/article_291983.html
https://eajbsc.journals.ekb.eg/service?article_code=291983
291,983
Original Article
673
Journal
Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology
https://eajbsc.journals.ekb.eg/
Hepatitis B Seroprevalence and Consequences in Khyber Pakhtunkhwa Peshawar, Pakistan
Details
Type
Article
Created At
24 Dec 2024